Novocure seeks approval after pancreatic cancer wearable scores at Phase III
Novocure is seeking regulatory approval in the US, EU, Japan and other key markets after the Phase III PANOVA-3 pancreatic…
All articles by Abigail Beaney
Abigail Beaney
Abigail Beaney is a healthcare reporter for the Clinical Trials Arena. Coming from a journalistic background Abigail holds a BA (Hons) in Journalism from the University of Central Lancashire. Based in Manchester, Abigail has previously worked in local news and has interests in research into the treatment and prevention of cancer, heart disease and dementia.
-
-
Trump triumphs but impact on healthcare industry remains unclear
Donald Trump has been elected 47th president of the US after the 5 November election having won more than the…
-
US Elections: how healthcare could look under a Harris or Trump administration
With less than three weeks before Americans head to the polls, the election race is heating up. It is still…
-
How will a Labour government support the UK clinical trials industry?
On 4 July 2024, the people of the UK took to the polls and made their voice heard, voting for…
-
Sponsors must take on FDA’s diversity guidance to improve community trust
The topic of improving diversity in clinical trials has been at the top of the agenda at most health conferences…
-
Mendel.ai software aims to save nurses time in pre-screening
California-based Mendel.ai has announced that a study utilising its artificial intelligence (AI) software alongside nurses has shown more accurate and…
-
NHS boss praises managers and leaders as Tories seek to scrap £1bn funding
The chief executive of the National Health Service (NHS) England spoke about her desire to ‘bolster management and leadership’ after…
-
ASCO 2024: Oncologists support Belong.Life’s AI cancer mentor Dave
Belong.Life has received validation from practising oncologists for the company's conversational AI oncology mentor Dave. The New York-based start-up published…
-
OCT Europe: Unless everyone is benefiting, what is the point?
Patient-centricity has been a buzzword in the clinical trial industry for the past few years with all the big pharma…
-
AI database to bolster research for GLP1-RAs as precision medicines
An AI database that utilises real-world data (RWD) could help sponsors decide where to next investigate glucagon-like peptide-1 receptor agonists…